GLIAL ACTIVATION STATES DURING MPTP-INDUCED DOPAMINERGIC DEGENERATION

• Leyre Ayerra,
• Miguel Angel Abellanas,
• Leyre Basurco,
• Adriana Tavira,
• Esther Luquin,
• Amaya Vilas,
• Ibon Tamayo,
• Mikel Hernaez,
• Pedro Clavero,
• Elisa Mengual,
• Sandra Hervás-Stubbs,
• Maria S. Aymerich

Affiliations

Leyre Ayerra

CIMA, Neuroscience Program, Pamplona (Navarra), Spain; Universidad de Navarra, Department Of Biochemistry And Genetics, Science School, Pamplona (Navarra), Spain

Miguel Angel Abellanas

CIMA, Neuroscience Program, Pamplona (Navarra), Spain; Universidad de Navarra, Department Of Biochemistry And Genetics, Science School, Pamplona (Navarra), Spain

Leyre Basurco

CIMA, Neuroscience Program, Pamplona (Navarra), Spain; Universidad de Navarra, Department Of Biochemistry And Genetics, Science School, Pamplona (Navarra), Spain

Adriana Tavira

CIMA, Neuroscience Program, Pamplona (Navarra), Spain; Universidad de Navarra, Department Of Biochemistry And Genetics, Science School, Pamplona (Navarra), Spain

Esther Luquin

Universidad de Navarra, Pathology, Anatomy And Physiology Department, Medical School, Pamplona (Navarra), Spain

Amaya Vilas

CIMA, Oncohematology Program, Pamplona (Navarra), Spain

Ibon Tamayo

CIMA, Computational Biology Program, Pamplona (Navarra), Spain

Mikel Hernaez

CIMA, Computational Biology Program, Pamplona (Navarra), Spain

Pedro Clavero

Hospital Center of Navarra, Neurology Service, Pamplona (Navarra), Spain

Elisa Mengual

Universidad de Navarra, Pathology, Anatomy And Physiology Department, Medical School, Pamplona (Navarra), Spain

Sandra Hervás-Stubbs

CIMA, Immunology Program, Pamplona (Navarra), Spain

Maria S. Aymerich

CIMA, Neuroscience Program, Pamplona (Navarra), Spain; Universidad de Navarra, Department Of Biochemistry And Genetics, Science School, Pamplona (Navarra), Spain